MATRITECH INC has a total of 56 patent applications. Its first patent ever was published in 1992. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are SARCOTEIN DIAGNOSTICS LLC, SCANTIBODIES LAB INC and NORDIC BIOSCIENCE AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 23 | |
#2 | WIPO (World Intellectual Property Organization) | 10 | |
#3 | Australia | 9 | |
#4 | EPO (European Patent Office) | 7 | |
#5 | Canada | 6 | |
#6 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Analysing materials | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations | |
#5 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Lidgard Graham P | 22 |
#2 | Keesee Susan K | 17 |
#3 | Wu Ying-Jye | 17 |
#4 | Obar Robert | 13 |
#5 | Miller Thomas E | 12 |
#6 | Beausang Lee Anne | 10 |
#7 | Toukatly Gary | 10 |
#8 | Watkins Brynmor | 8 |
#9 | Szaro Robert P | 7 |
#10 | Watkins Brynmor A | 4 |
Publication | Filing date | Title |
---|---|---|
WO2006034278A2 | Methods and compositions for detecting cancer using components of the u2 spliceosomal particle | |
AU2002306952A1 | Detection and treatment of colorectal cancer | |
US2002164664A1 | Detection and treatment of prostate cancer | |
US6936424B1 | Materials and methods for detection and treatment of breast cancer | |
US5858683A | Methods and compositions for the detection of cervical cancer | |
US5914238A | Materials and methods for detection of breast cancer | |
US5547928A | Methods and compositions for the detection of colon cancers | |
EP0647270A1 | Novel malignant cell type markers of the interior nuclear matrix | |
CA2122473A1 | Nuclear Matrix Protein Fluid Assay |